Growing community of inventors

Taranto, Italy

Daniela Melisi

Average Co-Inventor Count = 14.99

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Daniela Melisi ↔ Antonio Calignano (1 patent)Daniela Melisi ↔ Giovanna La Rana (1 patent)Daniela Melisi ↔ Maria Grazia Rimoli (1 patent)Daniela Melisi ↔ Rosario Cuomo (1 patent)Daniela Melisi ↔ Gianpiero Boatto (1 patent)Daniela Melisi ↔ Enrico Abignente (1 patent)Daniela Melisi ↔ Annalisa Curcio (1 patent)Daniela Melisi ↔ Elvira Luongo (1 patent)Daniela Melisi ↔ Oscar Sasso (1 patent)Daniela Melisi ↔ Giovanni Sarnelli (1 patent)Daniela Melisi ↔ Roberto Russo (1 patent)Daniela Melisi ↔ Maria Nieddu (1 patent)Daniela Melisi ↔ Carla Cirillo (1 patent)Daniela Melisi ↔ Salvatore De Lucia (1 patent)Daniela Melisi ↔ Oscar Sasso (0 patent)Daniela Melisi ↔ Roberto Russo (0 patent)Daniela MelisiDaniela Melisi (1 patent)Antonio CalignanoAntonio Calignano (5 patents)Giovanna La RanaGiovanna La Rana (3 patents)Maria Grazia RimoliMaria Grazia Rimoli (1 patent)Rosario CuomoRosario Cuomo (1 patent)Gianpiero BoattoGianpiero Boatto (1 patent)Enrico AbignenteEnrico Abignente (1 patent)Annalisa CurcioAnnalisa Curcio (1 patent)Elvira LuongoElvira Luongo (1 patent)Oscar SassoOscar Sasso (1 patent)Giovanni SarnelliGiovanni Sarnelli (1 patent)Roberto RussoRoberto Russo (1 patent)Maria NiedduMaria Nieddu (1 patent)Carla CirilloCarla Cirillo (1 patent)Salvatore De LuciaSalvatore De Lucia (1 patent)Oscar SassoOscar Sasso (0 patent)Roberto RussoRoberto Russo (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,812 patents)

2. Stewart Italia Srl (1 from 1 patent)

3. Calignano, Antonio (0 patent)

4. Cuomo, Rosario (0 patent)

5. Boatto, Gianpiero (0 patent)

6. Rimoli, Maria Grazia (0 patent)


1 patent:

1. 8551958 - Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…